https://news.medxy.ai/zh/%e6%96%9c%e8%a7%86%e6%82%a3%e5%84%bf%e7%88%b6%e6%af%8d%e7%9a%84%e5%ae%b6%e6%97%8f%e6%80%a7%e5%88%86%e5%b8%83%e4%b8%8e%e7%ab%8b%e4%bd%93%e8%a7%86%e8%a7%89%e5%87%8f%e9%80%80%ef%bc%9a%e5%af%b9%e9%81%97/Medxy AIzh2026-06-12T00:04:52-07:00斜视患儿父母的家族性分布与立体视觉减退：对遗传研究的启示 https://news.medxy.ai/ja/%e6%96%9c%e8%a6%96%e5%85%90%e3%81%ae%e8%a6%aa%e3%81%ab%e3%81%bf%e3%82%89%e3%82%8c%e3%82%8b%e5%ae%b6%e6%97%8f%e5%86%85%e9%9b%86%e7%a9%8d%e3%81%a8%e4%bd%8e%e7%ab%8b%e4%bd%93%e8%a6%96%ef%bc%9a%e9%81%ba/Medxy AIja2026-06-12T00:04:34-07:00斜視児の親にみられる家族内集積と低立体視：遺伝学研究への示唆 https://news.medxy.ai/vi/mau-hinh-gia-dinh-cua-lac-va-giam-lap-the-thi-giac-o-cha-me-cua-tre-mac-benh-goi-y-cho-nghien-cuu-di-truyen/Medxy AIvi2026-06-12T00:04:11-07:00Mẫu hình gia đình của lác và giảm lập thể thị giác ở cha mẹ của trẻ mắc bệnh: gợi ý cho nghiên cứu di truyền https://news.medxy.ai/familial-patterns-of-strabismus-and-subnormal-stereopsis-in-parents-of-affected-children-implications-for-genetic-research/Medxy AIen2026-06-12T00:02:16-07:00Familial Patterns of Strabismus and Subnormal Stereopsis in Parents of Affected Children: Implications for Genetic Research https://news.medxy.ai/a-novel-approach-to-targeting-dll3-with-tarlatamab-in-a-patient-with-medullary-thyroid-carcinoma-after-progression-on-selpercatinib-2/Medxy AIen2026-06-11T22:59:01-07:00A Novel Approach to Targeting DLL3 with Tarlatamab in a Patient with Medullary Thyroid Carcinoma after Progression on Selpercatinib https://news.medxy.ai/zh/%e6%97%8b%e8%bd%ac%e6%a4%85%e8%bf%98%e6%98%af%e6%89%8b%e6%b3%95%e5%a4%8d%e4%bd%8d%ef%bc%9f%e5%8d%95%e7%ba%af%e6%80%a7bppv%e7%9a%84%e8%af%81%e6%8d%ae%e7%bb%bc%e8%bf%b0%e4%b8%8e%e4%b8%b4%e5%ba%8a/Medxy AIzh2026-06-11T22:55:05-07:00旋转椅还是手法复位？单纯性BPPV的证据综述与临床思考 https://news.medxy.ai/ja/%e9%9d%9e%e8%a4%87%e9%9b%91%e6%80%a7bppv%e3%81%ab%e5%af%be%e3%81%99%e3%82%8b%e5%9b%9e%e8%bb%a2%e6%a4%85%e5%ad%90%e7%99%82%e6%b3%95%e3%81%a8%e6%89%8b%e6%8a%80%e7%9a%84%e6%95%b4%e5%be%a9%e6%b3%95/Medxy AIja2026-06-11T22:54:43-07:00非複雑性BPPVに対する回転椅子療法と手技的整復法：エビデンスに基づくレビューと臨床的統合 https://news.medxy.ai/vi/ghe-xoay-hay-nghiem-phap-thu-cong-trong-bppv-khong-phuc-tap-tong-quan-dua-tren-bang-chung-va-tong-hop-lam-sang/Medxy AIvi2026-06-11T22:54:20-07:00Ghế xoay hay nghiệm pháp thủ công trong BPPV không phức tạp? Tổng quan dựa trên bằng chứng và tổng hợp lâm sàng https://news.medxy.ai/rotational-chair-vs-manual-maneuvers-for-non-complex-bppv-an-evidence-based-review-and-clinical-synthesis/Medxy AIen2026-06-11T22:51:34-07:00Rotational Chair vs. Manual Maneuvers for Non-Complex BPPV: An Evidence-Based Review and Clinical Synthesis https://news.medxy.ai/multiple-sclerosis-does-not-appear-to-worsen-in-hospital-outcomes-after-cardiovascular-surgery-but-routine-home-discharge-is-less-common/Medxy AIen2026-06-11T17:26:15-07:00Multiple Sclerosis Does Not Appear to Worsen In-Hospital Outcomes After Cardiovascular Surgery, but Routine Home Discharge Is Less Common https://news.medxy.ai/blood-cancer-proteins-plus-histoplasma-antibodies-improve-malignancy-assessment-in-indeterminate-pulmonary-nodules/Medxy AIen2026-06-11T16:34:46-07:00Blood Cancer Proteins Plus Histoplasma Antibodies Improve Malignancy Assessment in Indeterminate Pulmonary Nodules https://news.medxy.ai/pelvic-exenteration-for-recurrent-cervical-cancer-can-deliver-long-term-survival-but-survivorship-burden-remains-substantial/Medxy AIen2026-06-11T11:34:17-07:00Pelvic Exenteration for Recurrent Cervical Cancer Can Deliver Long-Term Survival, but Survivorship Burden Remains Substantial https://news.medxy.ai/pregnancy-in-women-with-vascular-malformations-carries-high-risks-of-postpartum-hemorrhage-and-symptom-worsening-while-thromboembolism-clusters-in-extensive-lower-extremity-disease/Medxy AIen2026-06-11T09:13:59-07:00Pregnancy in Women With Vascular Malformations Carries High Risks of Postpartum Hemorrhage and Symptom Worsening, While Thromboembolism Clusters in Extensive Lower-Extremity Disease https://news.medxy.ai/post-infection-gut-brain-disorders-affect-about-1-in-10-people-with-dgbi-worldwide-with-distinct-psychological-and-regional-patterns/Medxy AIen2026-06-10T20:59:16-07:00Post-infection Gut-Brain Disorders Affect About 1 in 10 People With DGBI Worldwide, With Distinct Psychological and Regional Patterns https://news.medxy.ai/prdm9-deficiency-identifies-a-predominant-molecular-subgroup-in-sporadic-hirschsprung-disease-and-enables-blood-based-risk-stratification/Medxy AIen2026-06-10T20:52:32-07:00PRDM9 Deficiency Identifies a Predominant Molecular Subgroup in Sporadic Hirschsprung Disease and Enables Blood-based Risk Stratification https://news.medxy.ai/ultra-early-remote-ischemic-postconditioning-after-thrombectomy-appears-safe-but-does-not-improve-90-day-stroke-recovery/Medxy AIen2026-06-10T20:16:26-07:00Ultra-Early Remote Ischemic Postconditioning After Thrombectomy Appears Safe but Does Not Improve 90-Day Stroke Recovery https://news.medxy.ai/postmenopausal-migraine-signals-higher-ischemic-stroke-risk-not-hemorrhagic-stroke-in-the-womens-health-initiative/Medxy AIen2026-06-10T19:30:11-07:00Postmenopausal Migraine Signals Higher Ischemic Stroke Risk, Not Hemorrhagic Stroke, in the Women’s Health Initiative https://news.medxy.ai/hypertension-related-high-risk-features-may-identify-which-patients-with-cryptogenic-stroke-benefit-from-apixaban-instead-of-aspirin/Medxy AIen2026-06-10T19:13:48-07:00Hypertension-Related High-Risk Features May Identify Which Patients With Cryptogenic Stroke Benefit From Apixaban Instead of Aspirin https://news.medxy.ai/a-novel-approach-to-targeting-dll3-with-tarlatamab-in-a-patient-with-medullary-thyroid-carcinoma-after-progression-on-selpercatinib/Medxy AIen2026-06-10T19:11:43-07:00A Novel Approach to Targeting DLL3 with Tarlatamab in a Patient with Medullary Thyroid Carcinoma after Progression on Selpercatinib https://news.medxy.ai/a-three-mirna-plasma-signature-may-help-detect-early-beta-cell-dysfunction-before-overt-type-2-diabetes-progression/Medxy AIen2026-06-10T19:08:42-07:00A Three-miRNA Plasma Signature May Help Detect Early Beta Cell Dysfunction Before Overt Type 2 Diabetes Progression https://news.medxy.ai/ja/%e7%8f%be%e4%bb%a3%e8%a8%ba%e6%96%ad%e6%99%82%e4%bb%a3%e3%81%ab%e3%81%8a%e3%81%91%e3%82%8b%e5%9f%b9%e9%a4%8a%e9%99%b0%e6%80%a7%e6%84%9f%e6%9f%93%e6%80%a7%e5%bf%83%e5%86%85%e8%86%9c%e7%82%8e%ef%bc%9a/Medxy AIja2026-06-10T18:42:19-07:00現代診断時代における培養陰性感染性心内膜炎：全国コホートでみた患者背景と多様性 https://news.medxy.ai/vi/viem-noi-tam-mac-nhiem-khuan-am-tinh-voi-nuoi-cay-trong-ky-nguyen-chan-doan-hien-dai-dac-diem-benh-nhan-va-tinh-khong-dong-nhat-trong-mot-doan-he-toan-quoc/Medxy AIvi2026-06-10T18:41:53-07:00Viêm nội tâm mạc nhiễm khuẩn âm tính với nuôi cấy trong kỷ nguyên chẩn đoán hiện đại: Đặc điểm bệnh nhân và tính không đồng nhất trong một đoàn hệ toàn quốc https://news.medxy.ai/culture-negative-infective-endocarditis-in-the-modern-diagnostic-era-patient-characteristics-and-heterogeneity-in-a-nationwide-cohort/Medxy AIen2026-06-10T18:41:04-07:00Culture-Negative Infective Endocarditis in the Modern Diagnostic Era: Patient Characteristics and Heterogeneity in a Nationwide Cohort https://news.medxy.ai/vi/vo-mang-xo-vua-im-lang-o-cac-ton-thuong-khong-tac-nghen-cua-dong-mach-khong-lien-quan-den-nhoi-mau-chup-hinh-anh-vanh-tuan-tu-cho-thay-gi/Medxy AIvi2026-06-10T18:25:22-07:00Vỡ mảng xơ vữa im lặng ở các tổn thương không tắc nghẽn của động mạch không liên quan đến nhồi máu: Chụp hình ảnh vành tuần tự cho thấy gì? https://news.medxy.ai/silent-plaque-ruptures-in-non-obstructive-lesions-of-non-infarct-related-arteries-what-serial-coronary-imaging-reveals/Medxy AIen2026-06-10T18:24:28-07:00Silent Plaque Ruptures in Non-Obstructive Lesions of Non-Infarct-Related Arteries: What Serial Coronary Imaging Reveals https://news.medxy.ai/low-level-airborne-particulate-matter-and-risk-of-hypertension-hospitalization-in-older-u-s-adults-2/Medxy AIen2026-06-10T16:48:00-07:00Low-Level Airborne Particulate Matter and Risk of Hypertension Hospitalization in Older U.S. Adults https://news.medxy.ai/individual-glp-1-receptor-agonists-and-sglt2-inhibitors-show-largely-comparable-cardiovascular-protection-in-type-2-diabetes/Medxy AIen2026-06-10T16:41:27-07:00Individual GLP-1 Receptor Agonists and SGLT2 Inhibitors Show Largely Comparable Cardiovascular Protection in Type 2 Diabetes https://news.medxy.ai/zh/%e4%bd%93%e9%87%8d%e6%8c%87%e6%95%b0%e5%a6%82%e4%bd%95%e5%bd%b1%e5%93%8d%e5%bf%83%e5%8a%9b%e8%a1%b0%e7%ab%ad%e7%bb%93%e5%b1%80%ef%bc%9a%e6%9d%a5%e8%87%aa%e5%ad%9f%e5%be%b7%e5%b0%94%e9%9a%8f%e6%9c%ba/Medxy AIzh2026-06-10T16:38:53-07:00体重指数如何影响心力衰竭结局：来自孟德尔随机化研究的启示 https://news.medxy.ai/vi/bmi-anh-huong-the-nao-den-ket-cuc-o-suy-tim-goc-nhin-tu-nghien-cuu-randomization-mendel/Medxy AIvi2026-06-10T16:38:24-07:00BMI ảnh hưởng thế nào đến kết cục ở suy tim? Góc nhìn từ nghiên cứu randomization Mendel https://news.medxy.ai/oral-nlrp3-inhibition-with-ruvonoflast-produces-rapid-reversible-suppression-of-residual-inflammation-in-adults-at-high-cardiovascular-risk/Medxy AIen2026-06-10T16:37:48-07:00Oral NLRP3 Inhibition With Ruvonoflast Produces Rapid, Reversible Suppression of Residual Inflammation in Adults at High Cardiovascular Risk https://news.medxy.ai/exploring-the-impact-of-body-mass-index-on-heart-failure-outcomes-insights-from-mendelian-randomization/Medxy AIen2026-06-10T16:37:48-07:00Exploring the Impact of Body Mass Index on Heart Failure Outcomes: Insights from Mendelian Randomization https://news.medxy.ai/ja/%e4%bd%8e%e6%bf%83%e5%ba%a6%e3%81%ae%e5%a4%a7%e6%b0%97%e4%b8%ad%e7%b2%92%e5%ad%90%e7%8a%b6%e7%89%a9%e8%b3%aa%e3%81%a8%e7%b1%b3%e5%9b%bd%e9%ab%98%e9%bd%a2%e8%80%85%e3%81%ab%e3%81%8a%e3%81%91%e3%82%8b/Medxy AIja2026-06-10T16:35:27-07:00低濃度の大気中粒子状物質と米国高齢者における高血圧症入院リスク https://news.medxy.ai/vi/bui-min-trong-khong-khi-o-muc-thap-van-lam-tang-nguy-co-nhap-vien-vi-tang-huyet-ap-o-nguoi-cao-tuoi-hoa-ky/Medxy AIvi2026-06-10T16:35:07-07:00Bụi mịn trong không khí ở mức thấp vẫn làm tăng nguy cơ nhập viện vì tăng huyết áp ở người cao tuổi Hoa Kỳ https://news.medxy.ai/low-level-airborne-particulate-matter-and-risk-of-hypertension-hospitalization-in-older-u-s-adults/Medxy AIen2026-06-10T16:34:25-07:00Low-Level Airborne Particulate Matter and Risk of Hypertension Hospitalization in Older U.S. Adults https://news.medxy.ai/ja/%e5%bf%83%e4%b8%8d%e5%85%a8%e3%81%ab%e3%81%8a%e3%81%91%e3%82%8bbmi%e3%83%bb%e8%87%a8%e5%ba%8a%e8%bb%a2%e5%b8%b0%e3%83%bb%e6%ad%bb%e4%ba%a1%e7%8e%87%ef%bc%9a%e3%83%a1%e3%83%b3%e3%83%87%e3%83%ab/Medxy AIja2026-06-10T16:21:46-07:00心不全におけるBMI・臨床転帰・死亡率：メンデルランダム化研究 https://news.medxy.ai/vi/chi-so-khoi-co-the-ket-cuc-lam-sang-va-tu-vong-o-benh-nhan-suy-tim-nghien-cuu-ngau-nhien-hoa-mendel/Medxy AIvi2026-06-10T16:21:32-07:00Chỉ số khối cơ thể, kết cục lâm sàng và tử vong ở bệnh nhân suy tim: Nghiên cứu ngẫu nhiên hóa Mendel https://news.medxy.ai/body-mass-index-clinical-outcomes-and-mortality-in-heart-failure-a-mendelian-randomization-study/Medxy AIen2026-06-10T16:20:57-07:00Body Mass Index, Clinical Outcomes, and Mortality in Heart Failure: A Mendelian Randomization Study https://news.medxy.ai/ja/%e5%bf%83%e4%b8%8d%e5%85%a8%e3%81%ab%e3%81%8a%e3%81%91%e3%82%8b%e9%80%a3%e7%b6%9a%e3%83%a2%e3%83%8b%e3%82%bf%e3%83%aa%e3%83%b3%e3%82%b0%e4%b8%8b%e3%81%ae%e4%b8%8d%e6%95%b4%e8%84%88%e8%b2%a0%e8%8d%b7-2/Medxy AIja2026-06-10T16:20:55-07:00心不全における連続モニタリング下の不整脈負荷と臨床反応――ALLEVIATE-HF試験からの観察 https://news.medxy.ai/arrhythmia-burden-and-clinical-responses-under-continuous-monitoring-in-heart-failure-observations-from-the-alleviate-hf-trial-3/Medxy AIen2026-06-10T16:19:45-07:00Arrhythmia Burden and Clinical Responses Under Continuous Monitoring in Heart Failure: Observations From the ALLEVIATE-HF Trial https://news.medxy.ai/ja/%e5%bf%83%e4%b8%8d%e5%85%a8%e3%81%ab%e3%81%8a%e3%81%91%e3%82%8b%e7%b6%99%e7%b6%9a%e3%83%a2%e3%83%8b%e3%82%bf%e3%83%aa%e3%83%b3%e3%82%b0%e4%b8%8b%e3%81%ae%e4%b8%8d%e6%95%b4%e8%84%88%e8%b2%a0%e8%8d%b7/Medxy AIja2026-06-10T16:19:09-07:00心不全における継続モニタリング下の不整脈負荷と臨床反応：ALLEVIATE-HF試験からの知見 https://news.medxy.ai/vi/ganh-nang-roi-loan-nhip-va-dap-ung-lam-sang-khi-theo-doi-lien-tuc-o-benh-nhan-suy-tim-quan-sat-tu-thu-nghiem-alleviate-hf/Medxy AIvi2026-06-10T16:18:48-07:00Gánh nặng rối loạn nhịp và đáp ứng lâm sàng khi theo dõi liên tục ở bệnh nhân suy tim: Quan sát từ thử nghiệm ALLEVIATE-HF https://news.medxy.ai/arrhythmia-burden-and-clinical-responses-under-continuous-monitoring-in-heart-failure-observations-from-the-alleviate-hf-trial-2/Medxy AIen2026-06-10T16:17:58-07:00Arrhythmia Burden and Clinical Responses Under Continuous Monitoring in Heart Failure: Observations From the ALLEVIATE-HF Trial https://news.medxy.ai/ja/%e9%ab%98%e3%81%84%e5%bf%83%e8%a1%80%e7%ae%a1%e3%83%aa%e3%82%b9%e3%82%af%e3%82%92%e6%9c%89%e3%81%99%e3%82%8b%e4%ba%ba%e3%81%ab%e3%81%8a%e3%81%91%e3%82%8bruvonoflast%e7%b5%8c%e5%8f%a3nlrp3%e9%98%bb/Medxy AIja2026-06-10T16:08:48-07:00高い心血管リスクを有する人におけるRuvonoflast経口NLRP3阻害の抗炎症効果 https://news.medxy.ai/ja/%e3%83%aa%e3%82%b9%e3%82%af%e3%81%ab%e5%9f%ba%e3%81%a5%e3%81%8f%e7%9c%8b%e8%ad%b7%e5%b8%ab%e4%b8%bb%e5%b0%8e%e3%81%ae%e5%80%8b%e5%88%a5%e5%8c%96%e5%bf%83%e4%b8%8d%e5%85%a8%e4%bb%8b%e5%85%a5%ef%bc%9aal/Medxy AIja2026-06-10T16:08:43-07:00リスクに基づく看護師主導の個別化心不全介入：ALLEVIATE-HF試験 https://news.medxy.ai/vi/ruvonoflast-uong-uc-che-nlrp3-giup-giam-viem-o-nguoi-co-nguy-co-tim-mach-cao/Medxy AIvi2026-06-10T16:08:33-07:00Ruvonoflast uống: Ức chế NLRP3 giúp giảm viêm ở người có nguy cơ tim mạch cao https://news.medxy.ai/ja/%e5%8f%af%e6%90%ac%e6%80%a7%e3%82%92%e5%82%99%e3%81%88%e3%81%9f-berlin-heart-excor-%e7%94%a8-active-driver%e3%80%81%e9%ab%98%e3%83%aa%e3%82%b9%e3%82%af%e5%b0%8f%e5%85%90-vad-%e8%a3%9c%e5%8a%a9/Medxy AIja2026-06-10T16:01:50-07:00可搬性を備えた Berlin Heart EXCOR 用 Active Driver、高リスク小児 VAD 補助で重大機器不具合ゼロを達成 https://news.medxy.ai/vi/excor-active-driver-cho-tre-em-khong-ghi-nhan-loi-thiet-bi-nghiem-trong-nao-trong-ho-tro-vad-nguy-co-cao/Medxy AIvi2026-06-10T16:01:17-07:00EXCOR Active Driver cho trẻ em: không ghi nhận lỗi thiết bị nghiêm trọng nào trong hỗ trợ VAD nguy cơ cao https://news.medxy.ai/a-mobility-enabled-active-driver-for-berlin-heart-excor-showed-zero-major-device-malfunctions-in-high-risk-pediatric-vad-support/Medxy AIen2026-06-10T15:58:38-07:00A Mobility-Enabled Active Driver for Berlin Heart EXCOR Showed Zero Major Device Malfunctions in High-Risk Pediatric VAD Support https://news.medxy.ai/ja/%e7%9c%8b%e8%ad%b7%e5%b8%ab%e4%b8%bb%e5%b0%8e%e3%81%ae%e5%80%8b%e5%88%a5%e5%8c%96%e5%bf%83%e4%b8%8d%e5%85%a8%e4%bb%8b%e5%85%a5%e3%82%92%e3%83%aa%e3%82%b9%e3%82%af%e3%81%ab%e5%bf%9c%e3%81%98%e3%81%a6/Medxy AIja2026-06-10T15:41:05-07:00看護師主導の個別化心不全介入をリスクに応じて行う試み――ALLEVIATE-HF試験 https://news.medxy.ai/vi/alleviate-hf-can-thiep-suy-tim-ca-the-hoa-do-dieu-duong-quan-ly-dua-tren-danh-gia-nguy-co/Medxy AIvi2026-06-10T15:40:43-07:00ALLEVIATE-HF: Can thiệp suy tim cá thể hóa do điều dưỡng quản lý dựa trên đánh giá nguy cơ https://news.medxy.ai/risk-based-nurse-managed-personalized-heart-failure-interventions-the-alleviate-hf-trial/Medxy AIen2026-06-10T15:39:57-07:00Risk-Based Nurse-Managed Personalized Heart Failure Interventions: The ALLEVIATE-HF Trial https://news.medxy.ai/vi/ganh-nang-roi-loan-nhip-va-dap-ung-lam-sang-khi-theo-doi-lien-tuc-o-suy-tim-ket-qua-tu-thu-nghiem-alleviate-hf/Medxy AIvi2026-06-10T15:29:32-07:00Gánh nặng rối loạn nhịp và đáp ứng lâm sàng khi theo dõi liên tục ở suy tim: Kết quả từ thử nghiệm ALLEVIATE-HF https://news.medxy.ai/arrhythmia-burden-and-clinical-responses-under-continuous-monitoring-in-heart-failure-findings-from-the-alleviate-hf-trial/Medxy AIen2026-06-10T15:28:43-07:00Arrhythmia Burden and Clinical Responses Under Continuous Monitoring in Heart Failure: Findings from the ALLEVIATE-HF Trial https://news.medxy.ai/ja/%e8%a1%80%e6%b8%85%e3%82%a4%e3%83%b3%e3%82%bf%e3%83%bc%e3%83%ad%e3%82%a4%e3%82%ad%e3%83%b36%e6%bf%83%e5%ba%a6%e3%81%af9%e3%81%a4%e3%81%ae%e5%bf%83%e8%a1%80%e7%ae%a1%e3%83%bb%e6%ad%bb%e4%ba%a1%e3%82%a2/Medxy AIja2026-06-10T14:39:49-07:00血清インターロイキン6濃度は9つの心血管・死亡アウトカムをどこまで予測できるか https://news.medxy.ai/vi/gia-tri-tien-luong-cua-nong-do-interleukin-6-trong-huyet-thanh-doi-voi-9-ket-cuc-tim-mach-va-tu-vong/Medxy AIvi2026-06-10T14:39:26-07:00Giá trị tiên lượng của nồng độ interleukin-6 trong huyết thanh đối với 9 kết cục tim mạch và tử vong https://news.medxy.ai/the-prognostic-value-of-serum-interleukin-6-concentrations-for-9-cardiovascular-and-mortality-outcomes/Medxy AIen2026-06-10T14:38:37-07:00The Prognostic Value of Serum Interleukin-6 Concentrations for 9 Cardiovascular and Mortality Outcomes https://news.medxy.ai/ja/2%e5%9e%8b%e7%b3%96%e5%b0%bf%e7%97%85%e6%88%90%e4%ba%ba%e3%81%ab%e3%81%8a%e3%81%91%e3%82%8b%e3%82%bb%e3%83%9e%e3%82%b0%e3%83%ab%e3%83%81%e3%83%89%e3%81%a8%e8%84%88%e7%b5%a1%e8%86%9c%e6%96%b0%e7%94%9f/Medxy AIja2026-06-10T14:25:42-07:002型糖尿病成人におけるセマグルチドと脈絡膜新生血管を伴う加齢黄斑変性：OHDSIネットワーク研究 https://news.medxy.ai/vi/semaglutide-va-thoai-hoa-diem-vang-tuoi-gia-tan-mach-o-nguoi-lon-mac-dai-thao-duong-typ-2-nghien-cuu-mang-luoi-ohdsi/Medxy AIvi2026-06-10T14:25:22-07:00Semaglutide và thoái hóa điểm vàng tuổi già tân mạch ở người lớn mắc đái tháo đường týp 2: Nghiên cứu mạng lưới OHDSI https://news.medxy.ai/semaglutide-and-neovascular-age-related-macular-degeneration-among-adults-with-type-2-diabetes-an-ohdsi-network-study/Medxy AIen2026-06-10T14:24:32-07:00Semaglutide and Neovascular Age-Related Macular Degeneration Among Adults with Type 2 Diabetes: An OHDSI Network Study